These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29221940)

  • 1. Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice.
    Shen D; Li H; Zhou R; Liu MJ; Yu H; Wu DF
    Exp Gerontol; 2018 Feb; 102():101-108. PubMed ID: 29221940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
    Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
    J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Response Modulation through a PPARγ Agonist during Surgically Induced Visceral Ischemia in an Animal Model.
    Pane B; Gazzola V; Spinella G; Bagnato P; Grillo F; Vellone VG; Palombo D
    Ann Vasc Surg; 2018 Apr; 48():189-194. PubMed ID: 29197607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
    Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
    Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
    Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E
    Muhammad RS; Abu-Saleh N; Kinaneh S; Agbaria M; Sabo E; Grajeda-Iglesias C; Volkova N; Hamoud S
    Atherosclerosis; 2018 Sep; 276():155-162. PubMed ID: 30075439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
    Yamamoto S; Zhong J; Yancey PG; Zuo Y; Linton MF; Fazio S; Yang H; Narita I; Kon V
    Atherosclerosis; 2015 Sep; 242(1):56-64. PubMed ID: 26184694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
    Chen K; Yuan R; Zhang Y; Geng S; Li L
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
    Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
    Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
    Shi ST; Li YF; Guo YQ; Wang ZH
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
    Li S; Wang K; Xu G; Ji J; Qin C
    Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.